Back to top
more

Ingevity (NGVT)

(Real Time Quote from BATS)

$40.71 USD

40.71
21,339

+0.31 (0.77%)

Updated Aug 4, 2025 11:52 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (167 out of 246)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Ingevity (NGVT) Q1 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of -13.49% and 4.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Green Plains Renewable Energy (GPRE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Green Plains (GPRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Analysts Estimate Ingevity (NGVT) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Why You Should Keep Ingevity (NGVT) Stock in Your Portfolio

by Zacks Equity Research

Ingevity (NGVT) gains on solid demand and higher selling prices in its Performance Chemicals segment, actions to drive long-term growth and price hike measures to mitigate cost inflation.

Zacks Equity Research

Ingevity (NGVT) Benefits From Strong Demand and Growth Actions

by Zacks Equity Research

Ingevity (NGVT) gains on strength in its engineered polymers and industrial specialties businesses and actions to drive growth amid costs-related headwinds.

Zacks Equity Research

Ingevity (NGVT) Down 16.8% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Ingevity (NGVT) to Feature Capa at European Coatings Show

by Zacks Equity Research

Ingevity (NGVT) will showcase the benefits of using Capa technology and AltaVeg FA 120 at the European Coatings Show 2023.

Zacks Equity Research

Ingevity's (NGVT) Earnings and Revenues Miss Estimates in Q4

by Zacks Equity Research

Ingevity (NGVT) gains from higher pricing across its business amid headwinds from higher levels of consumer destocking weighing on its performance in Q4.

Zacks Equity Research

Ingevity (NGVT) Lags Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of -36.67% and 0.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ingevity (NGVT) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Axalta Coating Systems (AXTA) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 5.56% and 1.65%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ingevity (NGVT) Gains on Demand Strength and Growth Actions

by Zacks Equity Research

Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth amid costs-related headwinds.

Zacks Equity Research

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Ingevity (NGVT) Up 9.9% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Zacks Industry Outlook Highlights Ashland, Livent, Ingevity and Flexible Solutions International

by Zacks Equity Research

Ashland, Livent, Ingevity and Flexible Solutions International are part of the Zacks Industry Outlook article.

Anindya Barman headshot

4 Chemical Specialty Stocks to Escape Industry Challenges

by Anindya Barman

Slowing end-market demand and input cost pressure dampen prospects for the Zacks Chemicals Specialty industry. ASH, LTHM, NGVT and FSI are set to gain from self-help actions.

Zacks Equity Research

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Are Basic Materials Stocks Lagging Glencore (GLNCY) This Year?

by Zacks Equity Research

Here is how Glencore PLC (GLNCY) and Ingevity (NGVT) have performed compared to their sector so far this year.

Zacks Equity Research

Ingevity's (NGVT) Earnings and Sales Top Estimates in Q3

by Zacks Equity Research

Ingevity (NGVT) benefits from strong demand and actions to increase prices in the third quarter.

Zacks Equity Research

How Much Upside is Left in Ingevity (NGVT)? Wall Street Analysts Think 30%

by Zacks Equity Research

The mean of analysts' price targets for Ingevity (NGVT) points to a 30% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

Ingevity (NGVT) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Ingevity (NGVT) delivered earnings and revenue surprises of 21.51% and 12.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ingevity (NGVT) Wraps Up Expansion of Polyols Production

by Zacks Equity Research

The expansion at Ingevity's (NGVT) plant in DeRidder increases its global capacity for producing polyols by 40%.

Zacks Equity Research

Ingevity (NGVT) is a Top-Ranked Growth Stock: Should You Buy?

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Ingevity (NGVT) Gains on Demand Strength and Growth Actions

by Zacks Equity Research

Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth.